Navigation Links
Research network based at University of Toronto gets $5 million boost to speed up cancer detection
Date:9/24/2009

TORONTO, ON A nanomedicine research group led by a University of Toronto chemist has received a $5-million grant from the Natural Sciences and Engineering Research Council of Canada (NSERC), giving them the green light to develop faster ways of detecting leukemia and lung cancer cells.

"This funding will lead to healthier lives for Canadians," says Gilbert Walker, a professor in U of T's Department of Chemistry and primary investigator of the Network for Bioplasmonic Systems (BiopSys). "Our first goal is to determine the presence of lung cancer at an earlier stage than is currently possible, which will permit faster screening. Our second goal is to develop similar devices for detecting leukemia that will greatly decrease the time needed for diagnosis."

The BiopSys network aims to speed up cancer diagnosis by incorporating an emerging technology known as plasmonics into existing procedures that use cancer markers found on the surfaces of cells. Plasmonics a technique that produces waves of electrons when light hits a metal surface offers significant opportunities for increasing the number of types of cancer markers that can be identified simultaneously.

"Bioplasmonics uses light illumination and engineers it for the extremely sensitive detection of biological molecules," says Walker. "BiopSys will develop technologies that allow for more selective detection of diseases and other health conditions that are evident on cell surfaces."

The BiopSys network is one of two U of T projects to receive a $5-million funding boost through NSERC's Strategic Research Networks program, announced today at McMaster University. The other led by computer scientist Rene Miller, Bell Canada Chair of Information Systems at U of T looks at developing better information management systems for business, scientific, and government organizations.

"We are delighted that two of the nine networks created today are based at U of T," says Professor Paul Young, U of T's vice-president (research). "These grants fund large-scale multi-disciplinary projects that have the potential to bring great benefit to society in the coming years, and this is exactly the kind of work that Professor Walker is leading. We will look to him and others like him who are working closely with collaborators in academia and industry for innovations that will improve the nation's economy and the quality of life of its citizens."

The network, which will receive NSERC funding of $1 million per year for five years, is unique in that it brings together experts from a wide range of disciplines and skill sets. U of T researchers in the Departments of Chemistry, Electrical and Computer Engineering, Physics and the Faculty of Medicine are involved, as well as scientists from the Universities of Ottawa, Victoria, Western Ontario and Windsor. The team also includes scientists from the cole Polytechnique de Montral and Toronto's Mt. Sinai and Princess Margaret Hospitals as well as industrial partners.

"We are extremely grateful to NSERC for its continued investment in excellence and for its support of U of T research," says University of Toronto president David Naylor. "The BiopSys network represents a unique partnership between universities, industry and government that will lead to revolutionary improvements in cancer diagnosis. The network brings together some of the best minds from a wide range of disciplines, including biochemistry, engineering and physics. Through its industrial partners, BiopSys will be able to transfer that knowledge into practice quickly, developing equipment of significant value to Canadians."


'/>"/>

Contact: Sean Bettam
s.bettam@utoronto.ca
416-946-7950
University of Toronto
Source:Eurekalert

Related biology news :

1. AFOSRs basic research may lead to revolutionary new devices
2. New research network at McMaster aims to build a better eye
3. WPI receives $1.3 million in federal awards for ongoing research in the life sciences
4. Stem cell applications and research highlight NJITs first Research Cafe
5. NIH announces 115 awards to encourage high-risk research and innovation
6. New genetic research indicates Jewish priesthood has multiple lineages
7. Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research
8. UNC scientists garner new NIH awards for high risk, transformative research
9. Researchers identify new brain pathway for regulating weight and bone mass
10. McGill garners 19 Canada Research Chairs and more than $17 million in funding
11. Research team finds first evolutionary branching for bilateral animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
(Date:1/7/2016)... , Jan. 7, 2016 Various factors ... biopharmaceutical products such as biologics and biosimilars. Some ... reduce healthcare expenditure, growing demand for cost-effective alternatives, ... population. Biosimilars are similar versions of their corresponding ... to their quality, safety, and efficacy. The global ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/4/2016)... , February 4, 2016 Strasbourg, ... (ABL), Inc. --> Strasbourg, France , ... --> PharmaVentures is pleased to announce that it acted ... biopharmaceutical manufacturing unit in Strasbourg, France , ... --> --> Transgene (Euronext: TNG), ...
(Date:2/3/2016)... Feb. 3, 2016  Discovery Laboratories, Inc. (NASDAQ: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... approved an inducement award as a component of ... newly appointed President and Chief Executive Officer.  The ... on February 1, 2016 and granted as an ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
Breaking Biology Technology: